Etoposide (VP16) in the treatment of multisystem langerhans cell histiocytosis (histiocytosis X)-Reference-Cited by-同舟云学术

Etoposide (VP16) in the treatment of multisystem langerhans cell histiocytosis (histiocytosis X)

Published:1989 Issue:2 Volume:17 Page:97-100
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Broadbent V.,Pritchard J.,Yeomans E.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference15 articles.

1. Histiocytosis X--current controversies.

2. Histiocytosis X—an analysis of prognostic factors

3. (for the AIEOP Group): Prospective cooperative trial AIEOP-HX83 in childhood (15 years): Langerhans cell histiocytosis (Abstract). Histiocyte Society Meeting, Bethesda, 1987. Med Ped Onc (in press).

4. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16–213

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late Effects in Langerhans Cell Histiocytosis of Young Cancer Patients;Late Treatment Effects and Cancer Survivor Care in the Young;2020-11-06

2. Diagnosis and treatment of Langerhans Cell Histiocytosis with bone lesion in pediatric patient: A case report;Annals of Medicine and Surgery;2019-09

3. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India;Pediatric Blood & Cancer;2018-03-07

4. Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children’s Hospital in Shanghai, China;Journal of Pediatric Hematology/Oncology;2018-01

5. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study;Leukemia Research;2016-03